Limosilactobacillus reuteri-derived exopolysaccharides facilitate the repair of intestinal epithelium barrier compromised by chemotherapy exposure
RNA-seq (gene expression) · human · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 15 samples: 15 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE288972_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1220137 and SRA study SRP562044. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 15 sample titles: 15 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8780304 BEA24P061_GL_21_T2_5_FU_RNA
- GSM8780305 BEA24P061_GL_22_T2_5_FU_plus_LR_RNA
- GSM8780306 BEA24P061_GL_23_T2_5_FU_plus_EPS_RNA
- GSM8780307 BEA24P061_GL_24_T2_5_FU_plus_MV_RNA
- GSM8780308 BEA24P061_GL_25_T2_Chem_RNA
- GSM8780309 BEA24P061_GL_26_T3_5_FU_RNA
- GSM8780310 BEA24P061_GL_27_T3_5_FU_plus_LR_RNA
- GSM8780311 BEA24P061_GL_28_T3_5_FU_plus_EPS_RNA
- GSM8780312 BEA24P061_GL_29_T3_5_FU_plus_MV_RNA
- GSM8780313 BEA24P061_GL_30_T3_Chem_RNA
- GSM8780314 BEA24P061_GL_31_T4_5_FU_RNA
- GSM8780315 BEA24P061_GL_32_T4_5_FU_plus_LR_RNA
- GSM8780316 BEA24P061_GL_33_T4_5_FU_plus_EPS_RNA
- GSM8780317 BEA24P061_GL_34_T4_5_FU_plus_MV_RNA
- GSM8780318 BEA24P061_GL_35_T4_Chem_RNA
- GSE270568 Polyploid cancer cells reveal signatures of chemotherapy relapse [scRNA-seq] 605 samples shares chemotherapy
- GSE279390 Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial 540 samples shares chemotherapy
- GSE203071 Machine-learning detects non-invasive 5-hydroxymeythylcytosine biomarkers for predicting response to chemotherapy in patients with metastatic colorectal cancer 155 samples shares chemotherapy
- GSE271757 Pembrolizumab plus chemotherapy in frontline treatment of advanced epithelial ovarian cancer: clinical and translational results from a phase II trial 97 samples shares chemotherapy
- GSE291966 An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapy 92 samples shares chemotherapy
- GSE312881 Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy 71 samples shares chemotherapy
- GSE222556 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors [10x scRNA-seq] 67 samples shares chemotherapy
- GSE292601 Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1 62 samples shares chemotherapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.